StockData
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. (SLGL) stock

SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$53.36+0.53 (+1.00%)

Close on Nov 18, 2026Market cap $148.67MP/E –Yield –

Sol-Gel Technologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$7.54M. The highest annual figure on record is $2.96M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$7.54M–
FY2024Dec 31, 2024-$12.01M–
FY2023Dec 31, 2023-$29.31M–
FY2022Dec 31, 2022-$16.24M-648.0%
FY2021Dec 31, 2021$2.96M–
FY2020Dec 31, 2020-$30.23M–
FY2019Dec 31, 2019-$25.95M–
FY2018Dec 31, 2018-$33.52M–
FY2017Dec 31, 2017-$31.63M–
FY2016Dec 31, 2016-$20.76M–
FY2015Dec 31, 2015-$9.65M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.16M–
Q2 FY2025Jun 30, 2025$11.23M–
Q2 FY2024Jun 30, 2024$1.62M–
Q2 FY2023Jun 30, 2023-$6.53M–
Q2 FY2022Jun 30, 2022-$463.00K–
Q2 FY2021Jun 30, 2021-$8.04M–
Q2 FY2020Jun 30, 2020-$7.55M–
Q2 FY2019Jun 30, 2019-$5.29M–
Q2 FY2018Jun 30, 2018-$7.29M–

More Sol-Gel Technologies figures

See a number that looks wrong?